Analysis of Segments and Major Growth Areas in the Large and Small-Scale Bioprocessing Market

The bioprocessing sector, encompassing both large and small-scale operations, is on track for significant expansion in the coming years. This growth is propelled by various industry shifts and technological advancements that are reshaping how biologics and related products are developed and manufactured. Let's explore the market's size, key players, emerging trends, and major segments that define this dynamic field.

Projected Market Value and Growth Drivers in the Large and Small-Scale Bioprocessing Market
The market for large and small-scale bioprocessing is predicted to expand rapidly, reaching a valuation of $119.99 billion by 2030. This represents a strong compound annual growth rate (CAGR) of 11.8%. The anticipated growth is driven by rising demand for biologics and biosimilars, which are increasingly preferred for medical treatments. Additionally, the widespread adoption of single-use technologies is accelerating market progress. Personalized and precision medicine developments are also playing a crucial role, alongside the expanding contract development and manufacturing organization (CDMO) services sector. Another important factor is the growing emphasis on sustainable bioprocessing methods, which addresses environmental concerns within production processes. Key trends over the forecast period highlight the increased use of modular and single-use bioprocessing systems, the rising need for versatile small-scale bioprocessing in research and development, the growth of outsourcing and contract biomanufacturing, enhanced scalability from laboratory to commercial stages, and greater integration of upstream and downstream workflows.

Download a free report of the large and small-scale bioprocessing market report:
https://www.thebusinessresearchcompany.com/report/large-and-small-scale-bioprocessing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Corporations Shaping the Large and Small-Scale Bioprocessing Market
Several prominent companies are at the forefront of the large and small-scale bioprocessing market. These include major pharmaceutical and biopharmaceutical firms such as F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., and Bristol Myers Squibb Company. Other influential players include AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, AbbVie Inc., Amgen Inc., Biogen Inc., and Regeneron Pharmaceuticals Inc. Additionally, companies like Genentech Inc., Gilead Sciences Inc., Novo Nordisk A/S, CSL Limited, UCB S.A., Samsung Biologics, WuXi Biologics, and Boehringer Ingelheim contribute significantly to this market's development.

Noteworthy Acquisition Enhancing Bioprocessing Capabilities
In February 2025, Thermo Fisher Scientific Inc., a US-based leader in life-sciences technology, completed the acquisition of Solventum Corporation's Purification & Filtration business for around US$4.1 billion. This strategic move aims to bolster Thermo Fisher's bioprocessing portfolio by incorporating Solventum's advanced filtration and membrane technologies. As a result, Thermo Fisher is set to expand its biologics manufacturing capabilities, covering both upstream and downstream workflows. Solventum Corporation is recognized for its expertise in purification and filtration technologies applicable to biologics, industrial applications, and medical devices.

View the full large and small-scale bioprocessing market report:
https://www.thebusinessresearchcompany.com/report/large-and-small-scale-bioprocessing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Current Trends in the Large and Small-Scale Bioprocessing Industry
Companies in this sector are focusing on innovation to improve safety and performance, particularly in personal protective equipment (PPE) related to infection control. The development of next-generation personal protective shields aims to offer enhanced safety, greater comfort, and superior defense against airborne pathogens. These advanced shields feature improved materials and ergonomic designs that cater to the evolving needs of healthcare professionals.

For example, in March 2025, Stryker Corporation, a US-based medical technology company, introduced the Steri-Shield 8 personal protection system. This new PPE solution includes a customizable helmet with three contact points to ensure a secure and adjustable fit, accommodating long-haired users with a specialized ponytail path. It also provides a 22% wider field of vision and brighter helmet lighting. The redesigned fan system improves comfort by cooling both the front and back of the neck. The system's three toga styles offer AAMI level 4 (2012) protection, regarded as the highest standard for fluid and microbial barriers. Additional features include a sleeker battery design and a more efficient charging station, reflecting Stryker's commitment to advanced, user-centered PPE design.

Segment Breakdown of the Large and Small-Scale Bioprocessing Market
This market is divided into several key segments based on product type, mode, workflow, scale, and application. The product categories consist of bioreactors or fermenters, cell culture products, filtration assemblies, bioreactor accessories, bags and containers, and other related products. Regarding mode of operation, the market is split between in-house processing and outsourced services. Workflow segments include downstream processing, fermentation, and upstream processing. The scale dimension covers industrial and small-scale operations. Applications primarily span biopharmaceuticals, specialty industrial chemicals, and environmental aids.

Further subcategories provide more detail, such as types of bioreactors including single-use, stainless steel, and glass variants. Cell culture products cover media, sera and supplements, and reagents. Filtration assemblies include membrane filters, depth filters, and tangential flow filtration systems. Bioreactor accessories comprise spargers, impellers, sensors, and probes. Bags and containers feature single-use bags, storage containers, and transfer bags. Other products encompass mixers, tubing and connectors, and sampling systems.

Regional Market Outlook and Growth Patterns
As of 2024, North America holds the largest share of the large and small-scale bioprocessing market. However, the Asia-Pacific region is expected to experience the fastest growth in the upcoming years. The market analysis encompasses key areas such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa, offering a comprehensive perspective on global market movements and opportunities.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.